What is Narayana Hrudayalaya Ltd's market cap?

Narayana Hrudayalaya Ltd (NH) has a market capitalization of ₹37,772 Cr.

What sector is NH in?

Narayana Hrudayalaya Ltd operates in the Healthcare — Hospitals & Diagnostics sector.

What is NH's return on equity?

Narayana Hrudayalaya Ltd has a return on equity (ROE) of 19.2%.

Loading company...

Analyzing...

Narayana Hrudayalaya Ltd (NH) — Analysis, Financials, Intelligence | The Stock Filter

The Organism · Company Intelligence

Narayana Hrudayalaya Ltd

NH|BSE: 539551

Healthcare — Hospitals & DiagnosticsHealthcare & Life Scienceswww.narayanahealth.org

₹1,862.50

₹9.50 (-0.51%)|MCap ₹37,772 Cr

As of 16 Jun 2026 (End of Day)

Promoter: 0.6%Div Yield: 0.24%

52W Low ₹1,589.0052W High ₹2,370.20

Narayana Hrudayalaya Ltd. engages in the provision of medical and health care services. The company is headquartered in Bangalore, Karnataka and currently employs 11,726 full-time employees. The compa

Secular Currents

Theme Connections

Healthcare Access

Intelligence Profile

TSF Score

64/100

The Vitals · Company Health

Health Indicators

Shenanigan Score

5Clean

Trust Score

X-Ray

Concerns

No significant concerns identified

Watch

Nothing flagged for monitoring

Strengths

🟢Strong return on equity (19.2%)Business
🟢Efficient capital deployment (ROCE: 17.3%)Business
🟢Good profitability (Net margin: 11.3%)Business
🟢Healthy revenue growth (14.3% CAGR 3yr)Business
🟢Consistent dividend payerOpportunity

The Numbers · Key Metrics

ROE

19.2%

Revenue Growth 3yr

14.3%

Debt/Equity

0.53x

₹37,315 Cr

The Narrator · StoryTel Intelligence

FY2025Healthcare — Hospitals & DiagnosticsProduct Sales ModelModel:Revenue = Number of Patients × Average Revenue per Patient (ARPOB for hospitals; Revenue per Test for diagnostics)

Key Insight

“Services business in Healthcare — Hospitals & Diagnostics.”

The Revenue Story

₹5,483 Cr service revenue.

Total Income₹5,575 Cr

Revenue₹5,483 Cr(98.3% of Total Income)

Other Income₹92 Cr(1.7% of Total Income)

The Cost Story

Employee costs at 19.9% of revenue — primary cost driver.

EBITDA₹2,413 Cr(40.8%)

Other Expenses₹1,977 Cr(33.5%)

Employee₹1,093 Cr(18.5%)

Depreciation₹278 Cr(4.7%)

Finance Costs₹146 Cr(2.5%)

0.2%EBITDA Margin

EBITDA

40.8%

Other Expenses

33.5%

Employee

18.5%

Depreciation

4.7%

Finance Costs

2.5%

Key Metrics

ROE

19.2%

vs median 7.9%

ROCE

17.3%

vs median 11.3%

Net Margin

11.3%

vs median 9.3%

EBITDA Margin

21.9%

vs median 21.9%

Debt To Equity

0.53x

vs median 0.16x

Rev Growth 3yr

14.3%

vs median 12.4%

EPS Growth 3yr

32.2%

vs median 11.8%

Employee Cost Ratio

19.90x

Forward View · Management Guidance

GUIDANCEQ3FY26High Impact

“We believe going forward, oncology and cardiac will account for more than half of our revenue going forward.”

GUIDANCEQ3FY26High Impact

“We do expect that the path will be flat or mildly positive, like we had indicated earlier. So therefore, we do continue to hold our position that this acquisition will be EPS neutral for the group.”

FINANCIALQ2FY26— SandhyaHigh Impact

“we financed £150,000,000 of it. About 40,000,000 has gone in as equity and 150,000,000 has gone in as debt. The 40,000,000 equity has been funded from Cayman”

The Context · Where does it sit?

Sector Context

The Canopy · Sector KPIs

Sector KPIs

Healthcare — Hospitals & Diagnostics

KPI	Company	Sector Median
ROE	19.2%▲	7.9%
ROCE	17.3%▲	11.3%
Net Margin	11.3%▲	9.3%
EBITDA Margin	21.9%▼	21.9%
Debt To Equity	0.53x▲	0.16x
Rev Growth 3yr	14.3%▲	12.4%
EPS Growth 3yr	32.2%▲	11.8%
Employee Cost Ratio	19.90x	-

The Market · What is the market saying?

Market Signals

The Antenna · Media Intelligence

Media Signal

Moderate Impact

7d+0.81→30d+0.81

Based on 2 articles (0 in last 7 days)

The Numbers · Show me the data

Financials

No valuation data

Historical valuation data not available.

Financials

Revenue₹6,778 Cr

PBT₹933 Cr

EPS₹38.11

(₹ Cr)	TTM	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019
Revenue	₹6,778 Cr +23.6%	₹5,483 Cr +9.3%	₹5,018 Cr +10.9%	₹4,525 Cr +22.2%	₹3,701 Cr +43.3%	₹2,582 Cr -17.4%	₹3,128 Cr +9.3%	₹2,861 Cr
Other Income	₹98 Cr +6.3%	₹92 Cr +22.4%	₹75 Cr +14.9%	₹65 Cr +89.4%	₹35 Cr +22.7%	₹28 Cr +18.6%	₹24 Cr +42.5%	₹17 Cr
Total Income	₹6,875 Cr +23.3%	₹5,575 Cr +9.5%	₹5,093 Cr +11.0%	₹4,590 Cr +22.9%	₹3,736 Cr +43.1%	₹2,611 Cr -17.2%	₹3,152 Cr +9.5%	₹2,878 Cr
COGS	₹1,315 Cr +15.7%	₹1,136 Cr +5.8%	₹1,074 Cr +7.3%	₹1,001 Cr +10.1%	₹909 Cr +34.1%	₹678 Cr -9.1%	₹745 Cr +8.4%	₹688 Cr
	₹5,883 Cr +27.0%	₹4,631 Cr +10.1%	₹4,205 Cr +9.5%	₹3,838 Cr +16.4%	₹3,298 Cr +24.0%	₹2,660 Cr -10.6%	₹2,976 Cr +7.0%	₹2,782 Cr
Profit Before Tax	₹933 Cr -0.2%	₹936 Cr +5.3%	₹889 Cr +18.2%	₹752 Cr +74.9%	₹430 Cr ↑ Recovery	(₹56 Cr) ↓ Decline	₹165 Cr +72.1%	₹96 Cr
Exceptional Items	(₹59 Cr) -609.1%	(₹8 Cr)	₹0.00 Cr +100.0%	(₹0.19 Cr) +97.7%	(₹9 Cr) -24.7%	(₹7 Cr) +37.1%	(₹11 Cr)	₹0.00 Cr
	₹151 Cr +3.6%	₹146 Cr +47.3%	₹99 Cr -31.8%	₹145 Cr +65.4%	₹88 Cr ↑ Recovery	(₹42 Cr) ↓ Decline	₹42 Cr +23.8%	₹34 Cr
Net Profit	₹779 Cr -1.4%	₹791 Cr +0.1%	₹790 Cr +30.2%	₹607 Cr +77.3%	₹342 Cr ↑ Recovery	(₹14 Cr) ↓ Decline	₹119 Cr +100.8%	₹59 Cr
Profit (Owners)	₹779 Cr -1.4%	₹790 Cr +0.1%	₹789 Cr +30.2%	₹606 Cr +77.3%	₹342 Cr ↑ Recovery	(₹14 Cr) ↓ Decline	₹119 Cr +101.0%	₹59 Cr
Minority Interest	₹0.34 Cr -28.6%	₹0.48 Cr +31.5%	₹0.36 Cr +13.8%	₹0.32 Cr +68.3%	₹0.19 Cr	₹0.01 Cr -92.6%	₹0.14 Cr +25.9%	₹0.11 Cr
Other Comprehensive Income	₹94 Cr +179.3%	₹34 Cr +145.1%	₹14 Cr -75.7%	₹57 Cr +116.7%	₹26 Cr ↑ Recovery	(₹2 Cr) ↓ Decline	₹5 Cr ↑ Recovery	(₹0.41 Cr)
EPS	₹38.11	₹38.66	₹38.62	₹29.67	₹16.73	(₹0.70)	₹5.82	₹2.90
Diluted Shares	₹20 Cr	₹20 Cr	₹20 Cr	₹20 Cr	₹20 Cr	₹20 Cr	₹20 Cr	₹20 Cr
Profit Loss From Discontinued Operations After Tax	₹0.61 Cr -25.2%	₹0.81 Cr	₹0.00 Cr	₹0.00 Cr	₹0.00 Cr	₹0.00 Cr	₹0.00 Cr	₹0.00 Cr